Navigation Links
Gentiva(R) Health Services Announces Fourth Quarter and Fiscal 2007 Results, and Raises 2008 Outlook
Date:2/14/2008

espectively, resulting from the adoption of Statement of

Financial Accounting Standards No. 123 (Revised) "Share-Based Payment"

(SFAS 123(R)) as of January 2, 2006. Corresponding amounts for fiscal

2007 and 2006 were $6.8 million and $4.3 million, respectively. Such

amounts were reflected in corporate expenses.

6) Components of EBITDA included the following:

A) Restructuring and integration costs for the fourth quarter and

fiscal 2007 were $0.3 million and $2.4 million, respectively, and

for the fourth quarter and fiscal 2006 were $3.3 million and $7.7

million, respectively. These costs included the following items:

(i) $0.3 million and $2.4 million for the fourth quarters of 2007

and 2006, respectively, and $2.3 million and $6.1 million for

fiscal 2007 and 2006, respectively, resulting from restructuring

and integration activities relating to the Healthfield

acquisition; (ii) $0.1 million for fiscal 2007 and $0.9 million

for both the fourth quarter of 2006 and fiscal 2006 in connection

with a restructuring plan associated with the Company's hospice

operations; and (iii) $0.7 million for fiscal 2006 resulting from

a restructuring plan associated with the Company's CareCentrix

operations.

Restructuring and integration costs for the fourth quarters and

fiscal 2007 and 2006 were reflected as follows for segment

reporting purposes (dollars in millions):

4th Quarter Fiscal Year

2007 2006 2007 2006

Home Health $0.1 $0.6 $0.6 $2.3

CareCentrix - - - 0.7

Other Related Service
'/>"/>

SOURCE Gentiva Health Services, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Gentiva(R) Health Services and CIGNA HealthCare Extend National Homecare Contract Through January 31, 2011
2. Gentiva(R) Health Services Agrees to Acquire Major Home Health Provider in CON State of Mississippi
3. Gentiva(R) Health Services Promotes Boelsen to Senior Vice President, CareCentrix(R)
4. Gentiva(R) Health Services to Present January 8 at JPMorgan Healthcare Conference in San Francisco
5. Gentiva(R) Health Services to Present November 7 at CIBC Healthcare Conference in New York
6. Gentiva(R) Health Services Schedules Third Quarter Earnings Call and Web Cast for Thursday, November 1, 2007
7. Gentiva(R) Health Services Files Universal Shelf Registration Statement
8. XTend Medical (XMDC) Begins Remote Diabetic Telehealth Program
9. Underserved Women and Children in Oakland County Get Big Boost for Free Health Care from Chrysler 300C Lease Giveaway
10. AIDS Action Asks Mass. Public Health Council to Forge a State AIDS Plan to Help Stop HIV/AIDS Here
11. Is a Common Cold a Serious Health Condition?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... small and shouldn,t worry most users, researcher says , , ... take antidepressants may have a small but statistically significant ... not on the medications, a new study finds. , ... stressed Dr. Jordan W. Smoller, an associate professor of ... a report in the Dec. 14 issue of ...
(Date:12/14/2009)... team of scientists from the UC San Diego School ... a protein switch that helps prevent liver damage, including ... better understanding of how the protein, TAK1, works could ... disease and cancer. , "TAK1 appears to be ... Brenner, MD, professor of medicine and Dean of the ...
(Date:12/14/2009)... underdiagnosed, poorly treated and highly stigmatized, according to ... Rubin, M.D., Ph.D. So these Washington University physicians ... , In "Demystifying Psychiatry," Zorumski and Rubin, who ... psychiatric patients and helping patient families, say some ... treatment result from a lack of understanding psychiatry ...
(Date:12/14/2009)... Study links perceived age to physical, mental functioning , ... look younger than their age tend to live longer ... new study suggests. , The finding came from research ... who were given physical and cognitive tests and then ... at the photos and indicated the age they perceived ...
(Date:12/14/2009)... Lesions Quickly and Accurately for Biopsy , ... ... Dilon Diagnostics announced today that the U.S. Food and ... system for molecular imaging biopsy guidance. , , ,GammaLMc® ... 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2
... coaster ride could be sufficient enough to intensify abnormal heart ... threatening complications including heart attack.// ,Researchers from Germany ... 18 women) who volunteered to take a ride. The ride ... 62 metres above the ground, followed by a free fall, ...
... (sildenafil) can improve exercise capacity and functional ability in ... high pressure in the blood vessels that enter the ... report by Reuters, the findings, which appear in The ... study of 278 patients who were randomly selected to ...
... to South Africa with respect to the number of AIDS/HIV ... in India has revealed that the figures could be far ... numerous repots claiming a dramatic decline in the number of ... the release of the U.N. annual global report on AIDS ...
... of the National Cancer Institute conducted a meta-analysis of ... and the prevalence and associated mortality from colorectal cancer. ... of the Karolinska Institute in Stockholm, and colleagues. The ... at a 30 percent risk of developing colorectal cancer ...
... by the Canadian Lung Association suggests that Canadians know little ... cause of death in the country. //, ,The study ... Pulmonary Disease (COPD). In a provincial report card delivered by ... when it came to public and physician awareness, access to ...
... to combat the bird flu threat over the next four ... funding in Busan, Korea, where he is attending the Asia ... the World Health Organization (WHO), would get around 20 percent ... simulation exercise run by APEC to test the region's preparedness. ...
Other Medicine News:Health News:AIDS Picture In India Not As Rosy As It Seems To Be 2Health News:Canadians Oblivious About COPD, A Debilitating Lung Disease 2
(Date:12/14/2009)... Caliper Life Sciences, ... of tools and services for drug discovery and ... completed the sale of Xenogen Biosciences Corporation ("XenBio"), ... to Taconic Farms, Inc. for approximately $11 million. ... of Caliper,s acquisition of Xenogen Corporation in 2006. ...
(Date:12/14/2009)... The U.S. Food and Drug Administration (FDA) approved ... for the treatment of schizophrenia in adults, Eli ... announced today. ZYPREXA RELPREVV, a long-acting intramuscular injection, ... four weeks. ,, Different from both oral and ... for stable concentrations of the active drug to ...
(Date:12/14/2009)... Dec. 14 Oxygen Biotherapeutics, Inc. (OTC Bulletin ... board of directors with the addition of Lt. Gen. ... is chairman of Martin, Blanck & Associates, a federal ... With his addition, the company board now has nine ... 1968 as a medical officer and battalion surgeon in ...
Breaking Medicine Technology:Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 2FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 3FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 4FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 5FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 6FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 7FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults 8Oxygen Biotherapeutics, Inc. Expands Board of Directors 2SenesTech Announces New Vice President of Business Development 12862 1SenesTech Announces New Vice President of Business Development 12862 2Will IVF work for a particular patient 3F The answer may be found in her blood 9080 1Will IVF work for a particular patient 3F The answer may be found in her blood 9080 2Will IVF work for a particular patient 3F The answer may be found in her blood 9080 3This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 1This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 2This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 3This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 4This Summer EyeCare America and Celebrity Chefs Want You to Feast Your Eyes on Eye Healthy Foods 50489 5
... FRANCISCO, Calif., April 9, 2008 ,Poniard Pharmaceuticals, Inc. ... oncology, today announced that data from a Phase ... in patients with small,cell lung cancer (SCLC) will ... 1st,European Lung Cancer Conference in Geneva, Switzerland. The ...
... April 9, 2008 Nektar,Therapeutics (Nasdaq: NKTR ) ... partners for its inhaled insulin programs as a,result of ... Inc. An increase in the number of new cases ... compared to the control group. All,new incidences of lung ...
Other Medicine Technology:Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 2Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference 3Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients 2Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients 3
To elevate, dissect, scrape and apply traction to bone and soft tissue....
Palm Style Impactor Bone Awl with Ortho-Grip® silicone rubber handles and,stainless steel impactor caps....
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
The AV Plus DX pacing lead is designed for use with the St. Jude Medical Affinity VDR pulse generator. This single-lead pacing system provides reliable pacing therapy with the added benefits of AV sy...
Medicine Products: